Insmed, Inc. (INSM) News
Filter INSM News Items
INSM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
INSM News Highlights
- For INSM, its 30 day story count is now at 4.
- Over the past 18 days, the trend for INSM's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about INSM are RARE.
Latest INSM News From Around the Web
Below are the latest news stories about INSMED INC that investors may wish to consider to help them evaluate INSM as an investment opportunity.
Insmed Inc Chief Medical Officer Martina Flammer Sells 28,310 SharesOn December 22, 2023, Martina Flammer, the Chief Medical Officer of Insmed Incorporated (NASDAQ:INSM), sold 28,310 shares of the company's stock, according to a recent SEC Filing. |
Investors ignore increasing losses at Insmed (NASDAQ:INSM) as stock jumps 9.0% this past weekIf you want to compound wealth in the stock market, you can do so by buying an index fund. But in our experience... |
12 Most Promising Stocks to Buy According to Hedge FundsIn this article, we will take a look at the 12 most promising stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Promising Stocks to Buy According to Hedge Funds. Analysts and financial institutions are starting to release their 2024 market outlook reports and predictions and you […] |
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 14 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company. |
Insmed To Present at the Nasdaq 49th Investor ConferenceInsmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023, at 8:30 a.m. ET/1:30 p.m. GMT. |
Vanguard Group Inc Adds Shares in Insmed IncVanguard Group Inc, a prominent investment firm, has recently expanded its portfolio by acquiring additional shares in Insmed Inc (NASDAQ:INSM). On October 31, 2023, Vanguard Group Inc reported an addition of 1,089,800 shares in Insmed Inc, reflecting an 8.18% change in their holdings. The transaction was executed at a price of $25.06 per share, increasing Vanguard's total share count in Insmed to 14,410,356. |
Insmed To Present at Two November ConferencesInsmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences: |
Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the GlobeInsmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today holds its second annual Global Day of Good, with hundreds of Insmed employees volunteering simultaneously in their respective communities. |
The Insmed Inc (INSM) Company: A Short SWOT AnalysisUnpacking the Strengths, Weaknesses, Opportunities, and Threats of Insmed Inc (INSM) |
Insmed Incorporated (NASDAQ:INSM) Q3 2023 Earnings Call TranscriptInsmed Incorporated (NASDAQ:INSM) Q3 2023 Earnings Call Transcript October 26, 2023 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.11 EPS, expectations were $-1.04. Operator: Thank you for standing by. My name is Caleb Baker and I will be your conference operator today. At this time, I would like to welcome everyone to the […] |